| Brand Name | CADD® HIGH-VOLUME ADMINISTRATION SETS |
| Common Device Name | SET, ADMINISTRATION, INTRAVASCULAR |
| Manufacturer (Section D) |
| SMITHS MEDICAL ASD, INC. |
| 6000 nathan lane north |
| minneapolis MN 55442 |
|
| MDR Report Key | 7205600 |
| Report Number | 3012307300-2018-00139 |
| Device Sequence Number | 853946 |
| Product Code |
FPA
|
| UDI-Device Identifier | 10610586027376 |
| UDI-Public | 10610586027376 |
| Combination Product (Y/N) | N |
| Initial Reporter State | MI |
| Initial Reporter Country | US |
| PMA/510(K) Number | K031361 |
| Number of Events Summarized | 1 |
| Summary Report (Y/N) | N |
| Reporter Type |
Manufacturer
|
| Report Source |
consumer |
| Initial Reporter Occupation |
Other
|
| Type of Report
| Initial |
| Report Date (Section B) |
01/19/2018 |
| 1 Device was Involved in the Event |
|
| 1 Patient was Involved in the Event |
|
| Is this an Adverse Event Report? |
Yes
|
| Is this a Product Problem Report? |
No
|
| Operator of Device |
Lay User/Patient
|
| Device Expiration Date | 06/15/2022 |
| Device Catalogue Number | 21-7355-24 |
| Device Lot Number | 27X192 |
| Was the Report Sent to FDA? |
No
|
| Type of Report(Section G) | Thirty-Day |
| Initial Date Received by Manufacturer | 01/02/2018 |
| Initial Report FDA Received Date | 01/19/2018 |
Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N) |
No
|
If action reported to FDA under 21 USC 360i(g), list FDA-assigned Recall Number or include a statement | MW5073699 |
| Patient Sequence Number | 1 |
Concomitant Medical Products and Therapy/Usage Dates | NORMAL SALINE 2L BOLUS |
| Outcome Attributed to Adverse Event |
Required Intervention;
|
| Patient Age | 36 YR |
| Patient Weight | 70 |
|
|